Follow
Laura Airas
Laura Airas
Unknown affiliation
Verified email at utu.fi - Homepage
Title
Cited by
Cited by
Year
A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis
L Kappos, EW Radue, P O'Connor, C Polman, R Hohlfeld, P Calabresi, ...
New England Journal of Medicine 362 (5), 387-401, 2010
32522010
Ocrelizumab versus placebo in primary progressive multiple sclerosis
X Montalban, SL Hauser, L Kappos, DL Arnold, A Bar-Or, G Comi, ...
New england journal of medicine 376 (3), 209-220, 2017
19262017
Oral fingolimod (FTY720) for relapsing multiple sclerosis
L Kappos, J Antel, G Comi, X Montalban, P O'Connor, CH Polman, T Haas, ...
New England Journal of Medicine 355 (11), 1124-1140, 2006
13272006
Clinical relevance of brain volume measures in multiple sclerosis
N De Stefano, L Airas, N Grigoriadis, HP Mattle, J O’Riordan, ...
CNS drugs 28, 147-156, 2014
3822014
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open …
R Kapoor, PR Ho, N Campbell, I Chang, A Deykin, F Forrestal, N Lucas, ...
The Lancet Neurology 17 (5), 405-415, 2018
3322018
25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis
M Soilu-Hänninen, L Airas, I Mononen, A Heikkilä, M Viljanen, ...
Multiple Sclerosis Journal 11 (3), 266-271, 2005
3282005
Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension study
P O'connor, G Comi, X Montalban, J Antel, EW Radue, A De Vera, ...
Neurology 72 (1), 73-79, 2009
2312009
CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis
JH Mills, LF Thompson, C Mueller, AT Waickman, S Jalkanen, J Niemela, ...
Proceedings of the National Academy of Sciences 105 (27), 9325-9330, 2008
2282008
Differential regulation and function of CD73, a glycosyl-phosphatidylinositol–linked 70-kD adhesion molecule, on lymphocytes and endothelial cells
L Airas, J Niemelä, M Salmi, T Puurunen, DJ Smith, S Jalkanen
The Journal of cell biology 136 (2), 421-431, 1997
2271997
Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study
V Devonshire, E Havrdova, EW Radue, P O'Connor, L Zhang-Auberson, ...
The Lancet Neurology 11 (5), 420-428, 2012
2122012
Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice
JCC de Sa, L Airas, E Bartholome, N Grigoriadis, H Mattle, ...
Therapeutic advances in neurological disorders 4 (3), 139-168, 2011
1872011
Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results
G Comi, P O'Connor, X Montalban, J Antel, EW Radue, G Karlsson, ...
Multiple Sclerosis Journal 16 (2), 197-207, 2010
1842010
CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73.
L Airas, J Hellman, M Salmi, P Bono, T Puurunen, DJ Smith, S Jalkanen
The Journal of experimental medicine 182 (5), 1603-1608, 1995
1841995
In vivo detection of diffuse inflammation in secondary progressive multiple sclerosis using PET imaging and the radioligand 11C-PK11195
E Rissanen, J Tuisku, J Rokka, T Paavilainen, R Parkkola, JO Rinne, ...
Journal of Nuclear Medicine 55 (6), 939-944, 2014
1772014
Detection of microglial activation in an acute model of neuroinflammation using PET and radiotracers 11C-(R)-PK11195 and 18F-GE-180
AM Dickens, S Vainio, P Marjamäki, J Johansson, P Lehtiniemi, J Rokka, ...
Journal of nuclear medicine 55 (3), 466-472, 2014
1722014
Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta
M Saraste, H Irjala, L Airas
Neurological Sciences 28, 121-126, 2007
1722007
Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity
H Högel, E Rissanen, C Barro, M Matilainen, M Nylund, J Kuhle, L Airas
Multiple Sclerosis Journal 26 (2), 210-219, 2020
1352020
Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells
Finnish Multiple Sclerosis and Pregnancy Study Group Airas L laura. airas ...
Clinical & Experimental Immunology 151 (2), 235-243, 2008
1352008
Smouldering multiple sclerosis: the ‘real MS’
G Giovannoni, V Popescu, J Wuerfel, K Hellwig, E Iacobaeus, MB Jensen, ...
Therapeutic advances in neurological disorders 15, 17562864211066751, 2022
1292022
Pregnancy outcome in women with multiple sclerosis: results from a prospective nationwide study in Finland
A Jalkanen, A Alanen, L Airas, ...
Multiple Sclerosis Journal 16 (8), 950-955, 2010
1162010
The system can't perform the operation now. Try again later.
Articles 1–20